Park J M, Bauer S B, Freeman M R, Peters C A
Department of Urology, Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
J Urol. 1999 Sep;162(3 Pt 2):1110-4. doi: 10.1016/S0022-5347(01)68086-8.
We test the hypothesis that oxybutynin chloride inhibits bladder smooth muscle cell proliferation.
Cultured rat bladder smooth muscle cells were grown in Medium 199 supplemented with 10% fetal bovine serum in the presence of 0, 1, 10 and 100 microM. oxybutynin. Cell proliferation was assessed by counting cell numbers 48 and 96 hours after plating. To investigate the role of oxybutynin in bladder smooth muscle cell proliferation after mechanical stretch, cells were grown on silicone elastomer bottomed culture plates and subjected to cyclical stretch-relaxation for 48 hours in the presence of 10 microM. oxybutynin. Deoxyribonucleic acid synthesis was assessed by tritiated thymidine incorporation assay. To examine the effect of oxybutynin on stretch activated gene expression, bladder smooth muscle cells were subjected to stretch-relaxation for 2 hours with and without 10 microM. oxybutynin, and relative c-jun messenger (m) ribonucleic acid (RNA) levels were assessed by semiquantitative reverse transcriptase-polymerase chain reaction with normalization to glyceraldehyde-3-phosphate dehydrogenase mRNA levels.
The serum stimulated increase in bladder smooth muscle cell growth was inhibited by oxybutynin in a dose dependent manner. In bladder smooth muscle cells there was a 4.7-fold increase in deoxyribonucleic acid synthesis after mechanical stretch, which decreased by 40% (p <0.01) when cells were stretched in the presence of oxybutynin. Stretch stimulated significant increase in c-jun mNRA levels, which was significantly decreased by oxybutynin.
Oxybutynin chloride inhibits bladder smooth muscle cell proliferation induced by serum and mechanical stretch. A potential mechanism by which oxybutynin inhibits proliferation may be the down regulation of growth promoting genes, such as c-jun. We speculate that oxybutynin may be useful for preventing permanent hypertrophic bladder changes in addition to decreasing intravesical pressure.
我们验证氯化奥昔布宁抑制膀胱平滑肌细胞增殖这一假说。
将培养的大鼠膀胱平滑肌细胞接种于添加10%胎牛血清的199培养基中,分别加入0、1、10和100微摩尔的奥昔布宁。接种48小时和96小时后通过细胞计数评估细胞增殖情况。为研究奥昔布宁在机械牵张后对膀胱平滑肌细胞增殖的作用,将细胞接种于硅橡胶弹性体底面的培养板上,在10微摩尔奥昔布宁存在的情况下进行48小时的周期性牵张 - 松弛处理。通过氚标记胸腺嘧啶核苷掺入试验评估脱氧核糖核酸合成。为检测奥昔布宁对牵张激活基因表达的影响,对膀胱平滑肌细胞进行2小时的牵张 - 松弛处理,分别加入和不加入10微摩尔奥昔布宁,通过半定量逆转录 - 聚合酶链反应并以甘油醛 - 3 - 磷酸脱氢酶信使核糖核酸水平进行标准化来评估相对c - jun信使核糖核酸水平。
奥昔布宁以剂量依赖性方式抑制血清刺激的膀胱平滑肌细胞生长增加。在膀胱平滑肌细胞中,机械牵张后脱氧核糖核酸合成增加了4.7倍,当在奥昔布宁存在的情况下进行牵张时,该合成减少了40%(p<0.01)。牵张刺激显著增加了c - jun信使核糖核酸水平,而奥昔布宁可使其显著降低。
氯化奥昔布宁抑制血清和机械牵张诱导的膀胱平滑肌细胞增殖。奥昔布宁抑制增殖的潜在机制可能是下调生长促进基因,如c - jun。我们推测奥昔布宁除了降低膀胱内压外,可能对预防永久性膀胱肥厚性改变也有用。